Table 1 Baseline characteristics of individuals with T2D and controls

Age (years)

64.66 ± 18.31

69.96 ± 11.50

0.224

Weight (kg)

70.52 ± 7.25

71.21 ± 9.43

0.189

Height (m)

1.69 ± 0.08

1.62 ± 0.08

0.051

BMI (kg/m²)

24.59 ± 2.04

27.08 ± 4.73

0.013

Duration of diabetes (years)

–

32.25 ± 10.52

–

Rapid-acting insulin

 Novorapid

–

n = 2 (8.33%)

 Humalog

–

n = 4 (16.66%)

 Actrapid

–

n = 3 (12.50%)

Long-acting insulin

 Lantus

–

n = 13 (54.16%)

 Tresiba

–

n = 0

 Toujeo

–

n = 0

 Levemir

–

n = 1 (8.33%)

 Insulatard

–

n = 13 (54.16%)

Other hypoglycemic drugs

 Metformin

–

n = 15 (62.5%)

 Minidiab

–

n = 1 (4.16%)

 Janumet

–

n = 2 (8.33%%)

 Glibenclamide

–

n = 1 (4.16%)

 Januvia

–

n = 10 (41.66%)